This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
What Is A Global Index explains the concept of aggregating multiple national markets into a single benchmark, its diversification benefits, and typical investor applications.
11,782 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Meta Platforms is weighing a bold move into prediction markets, boosting investor interest and triggering a rally. An...
In 2026, one AI-focused stock has become the darling of bulls and analysts alike. This article dives into the reasons...
A wide-open weight-loss drug market has investors buzzing about Viking Therapeutics. This article breaks down the bul...
Tesla’s latest delivery numbers surprised many investors. Despite solid growth, the stock moved lower as analysts wei...
Joby Aviation stock surging has a few clear triggers: progress on electric air mobility, a strategic partnership with...
Asia’s aging demographics are fueling a surge in high-end longevity clinics and wellness residencies, creating new op...
Minutes from Warsh's first FOMC meeting show inflation concerns dominated the discussion, keeping markets guessing ab...
Memory names rebound sharply as AI-driven data-center demand returns, led by Western Digital and Seagate’s roughly 7%...
SK hynix kicked off trading at $170 on the Nasdaq, a 14% jump from the offering price of $149. The $26.5 billion deal...
A former U.S. soccer player has built a $20 billion-a-year tech company and now credits relentless resilience over na...
As the three-year mark of the Ripple-SEC ruling arrives, XRP has moved from regulator target to institutional asset, ...